Biography
Lynn Dorsey Bleil(Born 1963, US citizen)has served as a non‑executive member of the Board of Directors of Sonova Holding AG since 2016. She is a member of the Technology and Innovation Committee and the Audit Committee.Lynn Dorsey Bleil retired as Senior Partner (Director) from McKinsey & Company in the United States in 2013, after more than 25 years advising senior management teams and boards of healthcare companies. Her work focused on corporate and business unit strategy, mergers and acquisitions, and public policy across the healthcare value chain. She has served on the boards of Auspex Pharmaceuticals until its acquisition by Teva in March 2015, of DST Systems until its acquisition by SS&C in April 2018, and of Stericycle Inc. until its acquisition by Waste Management in November 2024. Lynn Dorsey Bleil holds a Bachelor’s degree in Chemical Engineering from Princeton University, USA, and a Master of Business Administration from the Stanford University Graduate School of Business, USA. Lynn Dorsey Bleil will not stand for re‑election at the 2026 Annual General Meeting.
Outside mandates
Listed companies:
- Member of the Board of Directors of Alcon Inc.
- Member of the Board of Directors of Amicus Therapeutics, Inc.
Other mandates:
- Chair of the Intermountain Healthcare Wasatch Back Hospitals Community Board (a non-profit organization)
Meeting attendance during the financial year 2024/25
- Regular Board of Directors meetings: 5 out of 5 meetings attended
- Additional calls of the Board of Directors: 1 out of 1calls attended
- Audit Committee: 4 out of 4 meetings and 1 out of 1calls attended
Holdings as per 31.03.2025
- Shares: 7,621
- Restricted Shares1): 2,969